Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO
Published March 2026 · Last reviewed May 2026
The Med Device Cyber Podcast · March 1, 2026 In this episode of The Med Device Cyber Podcast, hosts Christian and Trevor welcome guest Steven Smith to delve into the critical intersection of quality assurance, regulatory affairs, and cybersecurity in medtech. Steven, with over two decades of experience in the MedTech space, highlights that cybersecurity is a fundamental component of quality software and processes, not an afterthought. The discussion emphasizes the need for medical device manufacturers to integrate cybersecurity as a design input, understand and continuously reassess risks, and consider the real-world clinical user environment. The conversation also addresses the disconnect between fast-evolving cybersecurity threats and slow-moving regulations, particularly from agencies like the FDA and Europe's MDR. The experts stress that mere regulatory clearance does not equate to a good or safe product; instead, active ownership of risk and early consideration of cybersecurity in the product development lifecycle are essential for patient safety, faster market entry, and cost avoidance. They highlight that negligence in design and risk mitigation can result in devastating patient outcomes and costly recalls, asserting that
Key Takeaways
- Cybersecurity is an intrinsic component of quality software and processes, essential for patient safety, and should not be treated as an afterthought.
- Medical device manufacturers must embed cybersecurity into the design process, continuously reassessing risks given the evolving threat landscape and diverse user environments.
- Understanding the clinical workflow and user environment, including the varying skill sets and preferences of clinicians, is crucial for effective device design and risk mitigation.
- Early and proactive engagement with cybersecurity and risk management in product development helps accelerate time to market, reduce costs, and prevent patient harm.
- Regulatory clearance from bodies like the FDA and MDR does not absolve manufacturers of responsibility; continuous ownership of risk and real-world impact remain paramount.
- Focusing on fundamental security practices and understanding risks early can lead to greater efficiency and safety, akin to how mastering driving fundamentals leads to faster, safer racing.
- Prevention is better than cure
- in medical device cybersecurity. The episode encourages product security teams, regulatory leads, and engineers to prioritize comprehensive risk identification and mitigation, informed by direct clinical insights rather than solely regulatory minimums.
Listen on mdcpodcast.com · Watch on YouTube
Listen to this episode
Want help applying this to your own device program?
Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.